Baxter International · Model Gambro MARS System
Enhanced blood purification for the treatment of Hepatic Encephalopathy due to a decompensation of chronic liver disease , as well as drug overdose and poisonings. The Molecular Adsorbent Recirculating System (MARS) uses adsorber cartridges to remove drugs and toxins with an affinity for albumin. When combined with a Continuous Renal Replacement Therapy (CRRT) system, the MARS circuit expands the ability of the CRRT treatment to simultaneously remove not only water-soluble substances, but albumin-bound (lipophilic) substances as well. The blood in the extracorporeal circuit is pumped through the specialized MARS FLUX filter on the MARS system. Then, protein-bound and water-soluble substances pass through the membrane by diffusion and convection into the albumin-enriched dialysate. Next, the albumin dialysate passes through the Prisma® system diaFLUX filter to remove water-soluble substances, and continues through the MARS adsorbers to remove the lipophilic substances (i.e. drugs and poisons) bound to the albumin molecules in the MARS circuit. The regenerated albumin dialysate returns through the MARSFLUX filter to repeat this process for the duration of the treatment. The MARS therapy is today the most widely used extracorporeal liver support therapy. This therapy has been in clinical use outside the United States since 1993 and commercially available since 1999. The MARS system is used in 45 countries around the world and its safety and efficacy have been demonstrated by clinical experience with more than 15,000 patients (about 45,000 treatments) who have benefited from its use. The MARS® device is cleared for use in the U.S. in the treatment of drug overdose and poisonings as well as hepatic encephalopathy (HE) due to a decompensation of a chronic liver disease. It is not indicated in the U.S. as a bridge to liver transplant.
Failure patterns typical of this equipment class - general BMET reference, not verified against this exact unit's own service history unless flagged. Severity is a category-level estimate.
Symptoms: Blood leak alarm, treatment stop.
Root cause: Optical cell dirty or true leak.
Symptoms: Conductivity out of range, dialysate alarm.
Root cause: Mixing valve or sensor fault.
Symptoms: UF inaccuracy, weight alarm.
Root cause: Balance system / scale fault.
Symptoms: No infusion, air alarm.
Root cause: Occlusion or drive failure.
The parts a BMET typically services on this class of equipment. Service class and relative cost are general engineering estimates for the category, not figures from this unit's documentation. Part numbers appear only when pulled from this unit's own service manual. Always confirm intervals and pricing against the manufacturer.
Single-use.
| Part | Service class | Relative cost | R&R difficulty |
|---|---|---|---|
| Dialyzer (filter) Single-use. | Consumable | $$ | Easy |
| Conductivity cell / sensor | Periodic replacement | $$ | Moderate |
| Blood pump roller | Periodic replacement | $$ | Fairly easy |
| Heparin pump syringe drive | Periodic replacement | $$ | Moderate |
Relative cost: $ lowest · $$$$ highest service-part cost for this equipment class. Not a price.
Preventive-maintenance tasks typical of this equipment class. Perform to the manufacturer's procedure and your facility's policy - this is general reference, not a schedule for this specific unit.
A structured starting point derived from the failure modes above. Follow the manufacturer's service documentation for the actual procedure.
Where this class of equipment is typically deployed - general reference, not this unit's own placement record.
No documents available for this device yet.
Describe a symptom or error code. Bio answers from this device's own documented error codes, failure modes, parts, and guides.
Ask Bio →